News
Please enjoy the latest industry news aggregated from top Life Sciences sources including BioPharma Dive, FierceBiotech and STAT.
- In a momentous vote for Pelosi, House sends drug pricing reforms to President Biden’s desk
- Seagen loses arbitration case to Daiichi Sankyo over cancer drug technology
- WHO renames lineages of monkeypox, moving away from geographic links
- Pfizer’s new pneumococcal vaccine meets study goal in children
- Amgen’s low tax rates draw attention of top Democratic senator
- New Enhertu approval adds to growing role of well-known cancer target
- Wastewater monitoring identifies polioviruses in New York City
- STAT+: Up and down the ladder: The latest comings and goings
- STAT+: Pharmalittle: Two children died after getting Novartis gene therapy; monkeypox vaccine maker warns about splitting doses
- Opinion: Medicare cuts would undermine the movement to increasing in-home care
- Opinion: Psychedelics researchers and investors should focus on delivering therapy, not drugs
- Novartis reports deaths of two patients treated with Zolgensma gene therapy
- New data from several states show racial disparities in monkeypox infections
- STAT+: Wyden wants details on Amgen’s U.S. taxes as part of expanding probe into pharma practices
- STAT+: Novartis reports two children died from acute liver failure after treatment with Zolgensma gene therapy